BlackRock Fund Advisors - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 167 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$50,302,000
-7.8%
5,091,303
+12.7%
0.01%
-18.2%
Q3 2016$54,580,000
+45.3%
4,518,198
+3.8%
0.01%
+37.5%
Q2 2016$37,560,000
-7.8%
4,352,218
+1.2%
0.01%
-11.1%
Q1 2016$40,747,000
-44.0%
4,302,729
+2.5%
0.01%
-47.1%
Q4 2015$72,762,000
+22.1%
4,198,609
-5.4%
0.02%
+13.3%
Q3 2015$59,596,000
-37.1%
4,437,512
+5.7%
0.02%
-34.8%
Q2 2015$94,816,000
+57.9%
4,199,129
-0.1%
0.02%
+64.3%
Q1 2015$60,031,000
+51.6%
4,203,845
+2.5%
0.01%
+40.0%
Q4 2014$39,592,000
+15.8%
4,102,773
+9.2%
0.01%0.0%
Q3 2014$34,193,000
-7.9%
3,757,433
+0.0%
0.01%0.0%
Q2 2014$37,106,000
-26.2%
3,755,627
-5.1%
0.01%
-33.3%
Q1 2014$50,295,000
-4.7%
3,958,701
+12.4%
0.02%
-6.2%
Q4 2013$52,778,000
+35.6%
3,520,891
-0.1%
0.02%
+23.1%
Q3 2013$38,921,000
+60.1%
3,525,448
+15.3%
0.01%
+44.4%
Q2 2013$24,314,0003,058,3150.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Bellevue Group AG 318,000$3,841,0000.69%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders